Veracyte Inc
Veridion Score
Composite trend over time
Why is VCYT moving today?
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for VCYT.
VCYT insider activity
Veracyte Inc
2 insiders bought in the last 90 days
Net selling: -$23.5M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-22 | 2026-06-18 | EASTHAM KARIN | Insider | sell | $53.55 | 529 | 15,097 | $28K | SEC Form 4 |
| 2026-06-22 | 2026-06-18 | EASTHAM KARIN | Insider | sell | $52.78 | 3,200 | 15,626 | $169K | SEC Form 4 |
| 2026-06-04 | 2026-06-04 | Leite John | Insider | sell | $50.07 | 13,975 | 132,305 | $700K | SEC Form 4 |
| 2026-06-04 | 2026-06-04 | McGuire Annie | Insider | sell | $50.12 | 1,776 | 137,240 | $89K | SEC Form 4 |
| 2026-06-04 | 2026-06-04 | McGuire Annie | Insider | sell | $49.31 | 1,400 | 139,016 | $69K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 86 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moVCYT contract awards, year to date.
Public federal awards linked to this ticker.
VCYT lobbying filings, year to date.
Registered lobbying filings matched to Veracyte Inc.